---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-032260"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2026-07-07T12:30:39+00:00"
generated_at: "2026-07-07T12:35:19.664512+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Microbot Medical reports >100% revenue and customer growth for Q2 2026 vs Q1 2026

## Summary
- Revenue and new customers grew more than 100% in Q2 2026 compared to Q1 2026.
- LIBERTY System adopted by leading health systems in Massachusetts, North Carolina, Michigan, and Pennsylvania.
- Entered agreement with Lovell Government Services to serve federal healthcare systems including VHA, MHS, IHS.
- Received marketing clearance for LIBERTY system from Israeli Ministry of Health, first international approval.
- Plans to expand U.S. sales territories from 8 to 12 and enter international markets by end of 2026.

## SEC filing metadata
- accession: 0001493152-26-032260
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2026-07-07T12:30:39+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000149315226032260/0001493152-26-032260-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000149315226032260/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-032260
- JSON: https://secwatch.observer/filing/0001493152-26-032260.json
- Plain text: https://secwatch.observer/filing/0001493152-26-032260.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.